Mar 13, 2020

Sarcosine was postulated in 2009 as a biomarker for prostate cancer (PCa). Here, we assess plasma sarcosine as a biomarker that is complementary to prostate-specific antigen (PSA).Plasma sarcosine was...

Mar 10, 2020

International prostate symptom score (IPSS) is a marker of lower urinary tract symptom (LUTS) deterioration or improvement in benign prostate hyperplasia (BPH). Whereas changes in IPSS relative to bas...

Mar 10, 2020

Zi-shen pill (ZSP), a traditional Chinese medicine, is widely used for the treatment of benign prostatic hyperplasia (BPH) and has remarkable curative effect.To screen the potential 5-Lipoxygenase(5-L...

Mar 10, 2020

To investgate the effect of properative transitional zone index (TZI) on the outcome of transurethral resection of prostate (TURP). A retrospective analysis was performed on 206 patients with TURP w...

Mar 10, 2020

The impact of prostate zonal volume on erectile function and penile Doppler parameters is not yet settled.To assess the association between prostate zonal volume and erectile dysfunction in patients w...

Mar 10, 2020

To evaluate the impacts of hydrogen sulfide (H S) donor, sodium hydrogen sulfide (NaHS), and phosphodiesterase type-5 inhibitor (PDE5i), tadalafil per se and their combination treatment on partial bla...

Mar 05, 2020

Various two-dimension (2D) side-chain substituted benzo(1,2-b:4,5-b')dithiophene (BDT) block have been used to construct donor polymers, while the size effect of side-chains on photovoltaic performanc...

Mar 05, 2020

Urolift® system is a mini-invasive technique, proposed as an alternative treatment for classic surgery of benign prostatic hyperplasia (BPH). Our objective was to report the results of Urolift® syst...

Mar 05, 2020

Benign prostatic hyperplasia (BPH) is the most common urologic disorder affecting older men, necessitating medical or surgical intervention. Limited data exists regarding the effect these surgeries ha...

Mar 05, 2020

Benign Prostatic Hyperplasia (BPH) is benign tumor in male which is histopathologically known with an increase of epithelial cells and prostatic stroma. Androgens, estrogens, stroma-epithelial interac...

Mar 05, 2020

Computable phenotypes have the ability to utilize data within the electronic health record (EHR) to identify patients with certain characteristics. Many computable phenotypes rely on multiple types of...

Mar 02, 2020

Recently, we publish two case reports about association of nonspecific granulomatous prostatitis (NSGP) and eosinophilic metaplasia (EM) in benign prostatic epithelium. There is no investigation of la...

Mar 02, 2020

Urodynamic study (UDS) and ultrasonography (USG) both are established investigations to assess the patients of benign prostatic hyperplasia (BPH). It is known that the prostate mass (PM) and post-void...

Mar 02, 2020

Our study aims to determine the symptoms and frequency of lower urinary tract in female university students and its related factors.This cross-sectional study was conducted between January and June 20...

Mar 02, 2020

The aim of our study was to investigate noninvasive predictors for detrusor underactivity (DUA) in male patients with lower urinary tract symptoms (LUTS) and benign prostatic enlargement (BPE).A conse...

Feb 28, 2020

The two major long-term concerns associated with different options for the management of prostate cancer, (including surgery, radiotherapy, brachytherapy, cryotherapy, HIFU, etc.) include difficulties...

Feb 28, 2020

Progesterone receptor (PR) is a critical regulator in reproductive tissues that controls a variety of cellular processes. The objective of the study was to study the PR expression in patients with ben...

Feb 28, 2020

Robot-assisted simple prostatectomy (RASP) is a relatively new minimally invasive procedure for surgical treatment to manage symptomatic, therapy-refractory benign prostate hyperplasia (BPH) in prost...

Feb 28, 2020

Elevated estrogen (E) levels caused by aging or exposure to endocrine disrupting chemicals are related to prostate disease development. Sixty to seventy percent of prostate cancer or benign prostatic ...

Feb 28, 2020

To investigate the potential mechanism of the effect of metabolic syndrome (MetS) on prostate volume (PV) and the risk of benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) and the...